| Product Code: ETC9941392 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Companion Diagnostic Technologies Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Companion Diagnostic Technologies Market - Industry Life Cycle |
3.4 United Kingdom (UK) Companion Diagnostic Technologies Market - Porter's Five Forces |
3.5 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume Share, By Indications, 2021 & 2031F |
3.6 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 United Kingdom (UK) Companion Diagnostic Technologies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Rising prevalence of chronic diseases in the UK |
4.2.3 Growing focus on early disease detection and prevention |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 High cost associated with companion diagnostic technologies |
4.3.3 Limited reimbursement policies for companion diagnostics in the UK |
5 United Kingdom (UK) Companion Diagnostic Technologies Market Trends |
6 United Kingdom (UK) Companion Diagnostic Technologies Market, By Types |
6.1 United Kingdom (UK) Companion Diagnostic Technologies Market, By Indications |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Indications, 2021- 2031F |
6.1.3 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Inflammation and Autoimmune diseases, 2021- 2031F |
6.1.5 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Companion diagnostics in cardiovascular diseases, 2021- 2031F |
6.1.6 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Companion diagnostics in CNS disorders, 2021- 2031F |
6.1.7 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Companion diagnostics tests in virology diseases, 2021- 2031F |
6.1.8 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Companion Diagnostic Technologies Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.2.3 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.2.4 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By In-situ Hybridization, 2021- 2031F |
6.2.5 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Real Time PCR, 2021- 2031F |
6.2.6 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Gene Sequencing, 2021- 2031F |
6.2.7 United Kingdom (UK) Companion Diagnostic Technologies Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Companion Diagnostic Technologies Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Companion Diagnostic Technologies Market Export to Major Countries |
7.2 United Kingdom (UK) Companion Diagnostic Technologies Market Imports from Major Countries |
8 United Kingdom (UK) Companion Diagnostic Technologies Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostic technologies in clinical practice |
8.2 Number of partnerships and collaborations between diagnostic companies and pharmaceutical firms |
8.3 Rate of development and approval of companion diagnostic tests |
8.4 Patient outcomes and treatment efficacy improvement through companion diagnostics usage |
9 United Kingdom (UK) Companion Diagnostic Technologies Market - Opportunity Assessment |
9.1 United Kingdom (UK) Companion Diagnostic Technologies Market Opportunity Assessment, By Indications, 2021 & 2031F |
9.2 United Kingdom (UK) Companion Diagnostic Technologies Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 United Kingdom (UK) Companion Diagnostic Technologies Market - Competitive Landscape |
10.1 United Kingdom (UK) Companion Diagnostic Technologies Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Companion Diagnostic Technologies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here